![]() |
Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
which is synergistic with tamoxifen and/or herceptin when used against breast cancer cell lines (ie, still basic research) with implications for her2+ brain mets and herceptin resistance.
full article is free to all http://breast-cancer-research.com/co...df/bcr2419.pdf |
Re: Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
Thanks, Lani. This gives so much more hope for us ER+, Her2 + gals.
|
Re: Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
Thanks Lani,
Amelia |
Re: Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
Hmmmmmmmmmmmmmmm anybody heard about this drug NOW?
|
Re: Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
There's a clinical trial of the drug currently recruiting participants:
http://clinicaltrials.gov/ct2/show/NCT00721409 |
Re: Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
That said
Inclusion Criteria: * Inoperable estrogen receptor positive and HER2 negative breast cancer. |
Re: Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
Sorry. There's another clinical trial that does include Her2+ patients and is currently recruiting:
http://clinicaltrials.gov/ct2/show/N...0332991&rank=6 |
Re: Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
Lani,
you are just wonderful....always on the target with the latest reports. This is exciting news... Thanks, Jean |
Re: Dr. Slamon's latest paper on a new drug against ER+,her2+ bc
Thanks for the info Lani!!
|
| All times are GMT -7. The time now is 11:07 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021